Professor Creswell Eastman AO is a world-renowned endocrinologist with a primary interest in Iodine Deficiency Disorders. He is the Clinical Professor of Medicine at the University of Sydney School of Medicine and Consultant Emeritus to Westmead Hospital.
Professor Eastman recently spoke to Australian Health Journal about iodine deficiency in pregnancy preparation and the mother’s health during pregnancy. May is the time of the year for the Australian Thyroid Foundation’s (ATF) Thyroid Awareness Month and Professor Eastman spoke about why iodine deficiency has become an even greater risk in Australians in recent years. He stresses the importance of public health literacy and health care professionals (HCPs) having a better understanding of the disorders associated with iodine deficiency.
Recent research from The Lancet – March 2022 emphasises the consequences and risks of an inadequate amount of thyroid hormone at conception, during pregnancy and whilst breastfeeding.
‘Without an adequate amount of thyroid hormone mothers can be exposed to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia or eclampsia, which affect around 10% of pregnant women and are the leading causes of maternal and neonatal mortality worldwide. Mothers who suffer from hypertensive disorders during pregnancy are at increased risk of long-term cardiovascular consequences and hypertensive disorders in subsequent pregnancies. Evidence also indicates a risk of reduced cognitive ability to their offspring.
‘Knowing if you are genetically predisposed to Hashimoto’s or Graves’ Diseases, which are both thyroid autoimmune disorders is important to be aware of, to ensure all appropriate tests are ordered. Autoimmune disorders may predispose mothers to a thyroid problem during pregnancy’, says Professor Creswell Eastman, who also serves as the ATF’s Principal Medical Advisor.
‘Unnecessary risks to a pregnancy and the mother’s health during pregnancy and ongoing is something that can be avoided and prevented. Raising awareness and ensuring thyroid tests are ordered by GP’s, when couples are planning a family and when the pregnancy is confirmed are both essential.
You Might also like
-
Study on digital tool for pharmacists in aged care
In March 2022, the Australia government announced $350 million of funding over 4 years to employ on-site pharmacists in residential aged care, starting July 2023. In April 2023, the government made changes to the proposed on-site pharmacists, where the new program will now be delivered by and through community pharmacies. Regardless of how the model will be implemented, the goal remains the same – to improve quality use of medicines and medicines safety for aged care residents.
-
Reflecting on a pivotal year for pharmacy
Dr. Kate Wang, a Senior Lecturer in Pharmacy at RMIT University and Adjunct Senior Lecturer, University of Western Australia, has over a decade of experience in both hospital and community pharmacy settings.
Dr Wang spoke to Australian Health Journal on some of the key topics in 2024 that have been pivotal as a pharmacist, academic and researcher for the pharmacy profession.
-
Updated handbook on chronic kidney disease management in primary care
Kidney Health Australia’s latest kidney disease guide for primary care practitioners is expected to be pivotal in slowing down the rates of kidney failure, which have doubled in the past 20 years and if left unchecked will grow by a further 42% by 2030, according to the health charity.
With specific reference to new kidney treatments and culturally safe kidney care for First Nations Australians, the 5th edition of Chronic Kidney Disease (CKD) Management in Primary Care handbook, known as the ‘kidney bible’, is a significant step-up in enabling earlier diagnosis of kidney disease for GPs and other front-line healthcare professionals.